BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 29597259)

  • 1. The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma.
    Pezzuto F; Buonaguro L; Buonaguro FM; Tornesello ML
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29597259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma.
    Lu CY; Chen SY; Peng HL; Kan PY; Chang WC; Yen CJ
    Oncotarget; 2017 Jan; 8(4):6406-6418. PubMed ID: 28031532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma.
    Rashad NM; El-Shal AS; Shalaby SM; Mohamed SY
    Mol Cell Biochem; 2018 Oct; 447(1-2):125-136. PubMed ID: 29455432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma.
    Golabi P; Jeffers T; Younoszai Z; Otgonsuren M; Sayiner M; Mishra A; Venkatesan C; Younossi ZM
    Ann Hepatol; 2017; 16(4):555-564. PubMed ID: 28611258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
    Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
    Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.
    Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S
    Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.
    Sinn DH; Gwak GY; Cho J; Paik SW; Yoo BC
    PLoS One; 2014; 9(11):e112184. PubMed ID: 25372403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
    Zhang YC; Xu Z; Zhang TF; Wang YL
    World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.
    Chen PH; Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Chao Y; Lin HC; Wu JC
    Ann Hepatol; 2013; 12(2):263-73. PubMed ID: 23396738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.
    Makarova M; Krettek A; Valkov MY; Grjibovski AM
    Int J Circumpolar Health; 2013; 72():20282. PubMed ID: 23687637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
    Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Li J; Han X; Yu X; Xu Z; Yang G; Liu B; Xiu P
    J Exp Clin Cancer Res; 2018 Sep; 37(1):213. PubMed ID: 30176913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating microRNAs for the diagnosis of hepatocellular carcinoma.
    Peng C; Ye Y; Wang Z; Guan L; Bao S; Li B; Li W
    Dig Liver Dis; 2019 May; 51(5):621-631. PubMed ID: 30744930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
    World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of hepatitis-related hepatocellular carcinoma.
    But DY; Lai CL; Yuen MF
    World J Gastroenterol; 2008 Mar; 14(11):1652-6. PubMed ID: 18350595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
    Moldogazieva NT; Zavadskiy SP; Terentiev AA
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular Carcinoma in a Tertiary Referral Hospital in Indonesia: Lack of Improvement of One-Year Survival Rates between 1998-1999 and 2013-2014.
    Loho IM; Hasan I; Lesmana CR; Dewiasty E; Gani RA
    Asian Pac J Cancer Prev; 2016; 17(4):2165-70. PubMed ID: 27221913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.